Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates

Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction

(2021) Kaspar Broch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial

(2020) Paul M Ridker et al.   EUROPEAN HEART JOURNAL

Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial

(2020) David C. Tong et al.   CIRCULATION

Colchicine in Patients with Chronic Coronary Disease

(2020) Stefan M. Nidorf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

(2019) Jean-Claude Tardif et al.   NEW ENGLAND JOURNAL OF MEDICINE

OUP accepted manuscript

(2018)   EUROPEAN HEART JOURNAL

All roads lead to IL-6: A central hub of cardiometabolic signaling

(2018) Peter Libby et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy

(2018) Tianxi Cai et al.   JAMA Cardiology

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

(2016) Ola Kleveland et al.   EUROPEAN HEART JOURNAL

Inflammation and Atherosclerosis

(2014) Joshua Hartman et al.   Cardiology in Review

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

(2012)   LANCET